Delivery Order SPE2DB22D2007-SPE2DB25FH8LB

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FZ2Z0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $23,785.94, is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB24FN0W0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $91,134.36, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order and has a performance period ending on March 19, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB52D, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,155.07, is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there...
This federal contract award, identified as SPE2DB22D2206|SPE2DB24FEP46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $40,788.78. This is a Firm Fixed Price Delivery Order contract with a period of performance through December 12, 2023. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPA56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,451.48 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a period of performance ending on January 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, ID SPE2DB22D1017|SPE2DB25FF1LB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $21,335.40, is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH6TN, was granted by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $34,372.17 and a completion date of November 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
This federal contract award, with the ID SPE2DB20D1047|SPE2DB24FF79M, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $15,376.83, is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30 per package. The contract has an ultimate completion date of July 17, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, identified as SPE2DB22D3501|SPE2DB24FWT83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract, valued at $16,551.37, is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV8EE, was issued by the Defense Logistics Agency (DLA) and awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,330.98 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication, to support federal healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8LB
    Delivery Order

This federal contract award, SPE2DB22D2007|SPE2DB25FH8LB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $29,033.62 with a firm fixed price. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award did not have a set-aside designation, indicating open competition.

Generated 4/18/25, 2:14 PM